StockUS listing USFMSNYSEHealthcareDividend King

Fresenius Medical Care Corporation(FMS) Stock Analysis | Healthcare

USD --+0.00%
Reward55Moderate
Risk36Moderate
75%Data
Thin 4% profit margin · 4.3% dividend yield
USD —+0.00 (+0.00%) Previous close · NYSE
Market cap 10.61Bn
Reward Ratingⓘ55 Moderate reward assessment · 75% data coverage
Bottom 50% of stocksView factors
Risk Ratingⓘ36 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on FMS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Fresenius Medical Care Corporation?

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.

AI Brief Pro

The brief on Fresenius Medical Care Corporation

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Fresenius Medical Care Corporation?

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 10.61B, and a P/E ratio of 11.8x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (55)
Company Information
SectorHealthcare
IndustryMedical Care Facilities
P/E Ratio11.815
Beta0.794
Insider Activity
12M windowNo data
No insider activity data available for this ticker.